| The
following links are specific to:
Hydrogen Peroxide
Drug summary & history
List of FDA-Approved drugs
Drug forms to be completed
Examples of completed forms
INAD
study protocol
Material Safety Data Sheet (MSDS)
What's
the status of this drug's
approval
Study Summaries
Print
this drug fact sheet
Print
all drug fact sheets
Sign-up via the INAD Program Management System (IPMS)
Information on EPA's National Pollutant Discharge Elimination System (NPDES) Permits
Authorization & Categorical Exclusion Letters |
| Objective/purpose: |
Collect
supportive and pivotal data needed to establish the effectiveness and safety
of hydrogen peroxide to control mortality caused by ectoparasites in a variety of fish species. |
| Drug name: |
35% PEROX-AID®
(hydrogen peroxide) |
| Source of drug: |
Western Chemical Inc.
|
Address: |
1269 Lattimore Road
Ferndale, WA 98248 USA |
Contact: |
Attention:Jason Montgomery
Toll Free: 800-283-5292 ext 4175
Tel: 360-312-4175
email: jasonm@wchemical.com
webpage: http://www.wchemical.com/ |
| Target
pathogen(s): |
Ectoparasites of the genera Ambiphrya, Chilodonella, Dactylogyrus, Epistylis, Gyrodactylus, Ichthyobodo, Ichthyophthirius, Trichodina, Trichophrya, Argulus, Salmincola, Lernaea, and Ergasilus in freshwater fish species; and of the genera Neobenedenia, Amyloodinium, Cryptocaryon, and Uronema in marine fish species. |
| Method
of administration: |
Immersion bath |
| Treatment
dosage: |
Option A: 100 or 150mg/L
Option B: 50, 75 or 100mg/L
Option C: 200mg/L |
| Treatment
regimen: |
Option A: Treatment duration is 30 min; 3 consecutive or alternate days
Option B: Treatment duration is 60 min; 3 consecutive or alternate days
Option C: Treatment duration is 30 min; 3 consecutive or alternate days |
| Withdrawal
period: |
None. Fish may be allowed to enter the food chain immediately after treatment. |
| Required
test parameters: |
Investigator must collect mortality data throughout the 5 day pretreatment, treatment, and 10 day posttreatment periods. Investigator should also report general fish behavior and any possible adverse effects relating to treatment. |
| Limitations
or restrictions on use: |
Investigator must follow all instructions in the Study Protocol for INAD 11-669 regarding drug acquisition and handling, fish treatment and disposition, and data reporting requirements. |
| Required
INAD fee: |
$400.00 per facility per year |
| AADAP
contact for other information: |
Ms.
Bonnie Johnson, FWS - AADAP
Phone: 406-994-9905
Fax: 406-582-0242
email: bonnie_johnson@fws.gov |
| Disclaimer: |
Product and company names mentioned in this website, or mentioned in materials accessed via this website, are for informational purposes only. The mention of such does not imply endorsement by the Aquatic Animal Drug Approval Partnership, the U.S. Fish & Wildlife Service or any other organization of the U.S. Government. |
|
|
